New Delhi, April 1 GLP-1-based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity, but they carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday.Highlighting that...
New Delhi, March 21 Pharmaceutical companies Torrent Pharmaceuticals, Alkem Laboratories, and USV Ltd. launched Semaglutide-based generic diabetes treatment medication in the country on Saturday.Torrent Pharma launched its Semaglutide brands, Sembolic and Semalix, in both oral and injectable...
New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...
New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
New Delhi, March 17 Fake and falsified obesity drugs could be prompting a public health concern driven by high prices, a lack of insurance, and the desire to lose weight, according to a world report article published in The Lancet journal.Author Sophie Cousins, an Australian writer and health...
cardiovascular health
counterfeit drugs
diabetestreatment
drug safety
fda warning
glp-1 receptor agonists
mexico
mounjaro
obesity drugs
ozempic
pharmaceutical fraud
prescription drugs
public health
united states
weight loss
world health organization
New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...
Jamtara, March 7 – With the launch of the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), a ambitious public welfare initiative by the Narendra Modi government, the Jan Aushadhi Kendra located near Veer Kunwar Chowk in the Jamtara district of Jharkhand, is rapidly becoming a major...
Bhopal, February 15 – The Jan Aushadhi Kendra, established in the Rajgarh district of Madhya Pradesh, has become a new hub of activity, as patients and their relatives are flocking to the medical store to purchase highly subsidized medicines, which elsewhere are a significant financial burden...
affordable medicines
cancer treatment
department of pharmaceuticals
diabetestreatment
generic medicines
government healthcare
heart disease treatment
jan aushadhi kendra
madhya pradesh
ministry of chemicals and fertilizers
pharmaceuticals
pmbjp
pradhan mantri bharatiya janaushadhi pariyojana
rajgarh district hospital
rozad khurd
New Delhi, February 11 OneSource Speciality Pharma announced on Wednesday that, along with Hikma, it has received approval from the Saudi Food and Drug Authority for a generic version of the diabetes and weight reduction medication Ozempic.The company has partnered with Hikma Pharmaceuticals...
diabetestreatment
generic medication
hikma pharmaceuticals
mena region
onesource speciality pharma
ozempic
saudi food and drug authority
semaglutide
weight reduction medication